| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 43,773 | 31,198 | 27,369 | 39,889 | | Cost of Revenue | 36,435 | 32,524 | 31,048 | 39,300 | | | Gross Profit | 7,338 | (1,326) | (3,679) | 589 | | | Operating Expenses | | Research Development | 13,776 | 13,937 | 14,110 | 16,221 | | Selling General and Administrative | 17,365 | 18,264 | 26,310 | 26,170 | | Non Recurring |
-
| 264 | 7,679 | 4,873 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (23,803) | (33,791) | (51,778) | (46,675) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 279 | 673 | 699 | 1,887 | | Earnings Before Interest And Taxes | (23,524) | (33,118) | (51,079) | (44,788) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (23,524) | (33,118) | (51,079) | (44,788) | | Income Tax Expense | 377 | 32,728 | (13,136) | (14,828) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (23,901) | (65,846) | (37,943) | (29,960) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (23,901) | (65,846) | (37,943) | (29,960) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($23,901) | ($65,846) | ($37,943) | ($29,960) |
|
0.51% Nasdaq 
Income Statement
